Press Release
Celebrating the Results of Regenerative Medicine Spearheaded by the Foundation for Regenerative Medicine
Orange, CA- December 30, 2016
Foundation for Regenerative Medicine (FRM) is happy to announce the celebration of its first one year of successful results in helping people via the use of regenerative medicine therapies. Over 50 patients have been assisted with financial support and all of whom have had a significant benefit. The 100% success rate is accompanied by 0% side effects and no rejections of any type.
Most therapies dealt with one of four areas. The first focused on amniotic stem cell infusion with an occasional intrathecal injection. The second area of success was immunotherapy for end stage malignancies such as cancers that had otherwise failed traditional therapies. Third was the benefit of intravenous therapies to enhance regeneration of body parts such as liver, kidneys and brain. Last but not least was the rehabilitation program that was started within the last six months that focused on patients that had residual disabilities from stroke, Parkinson and head injury. 2017 anticipates significant increase in our ability to help patients in three core areas research, education and therapy with strategic alliances being developed in research and therapy.
Fostering regenerative medicine is the core goal of FRM, which was established in February 2016. Subsequently, FRM has supported stem cell therapies for deserving patients, established a research group at a medical clinic, created sites for virtual and extended reality device evaluations. We continue to focus on all aspects of the FRM mission: research, education and therapies. More information is available at our web site at regenerativefoundation.org.
Orange, CA- December 30, 2016
Foundation for Regenerative Medicine (FRM) is happy to announce the celebration of its first one year of successful results in helping people via the use of regenerative medicine therapies. Over 50 patients have been assisted with financial support and all of whom have had a significant benefit. The 100% success rate is accompanied by 0% side effects and no rejections of any type.
Most therapies dealt with one of four areas. The first focused on amniotic stem cell infusion with an occasional intrathecal injection. The second area of success was immunotherapy for end stage malignancies such as cancers that had otherwise failed traditional therapies. Third was the benefit of intravenous therapies to enhance regeneration of body parts such as liver, kidneys and brain. Last but not least was the rehabilitation program that was started within the last six months that focused on patients that had residual disabilities from stroke, Parkinson and head injury. 2017 anticipates significant increase in our ability to help patients in three core areas research, education and therapy with strategic alliances being developed in research and therapy.
Fostering regenerative medicine is the core goal of FRM, which was established in February 2016. Subsequently, FRM has supported stem cell therapies for deserving patients, established a research group at a medical clinic, created sites for virtual and extended reality device evaluations. We continue to focus on all aspects of the FRM mission: research, education and therapies. More information is available at our web site at regenerativefoundation.org.